Holen Sie sich die Stockscreener-App
73.43
1.28%
-0.95
Handel nachbörslich:
73.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
DNB Asset Management AS Acquires 803,086 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Banco Santander S.A. - MarketBeat
DexCom (DXCM) Expands Board with New Appointment - GuruFocus
Dexcom Adds Google Executive Rick Osterloh to Board - TipRanks
Dexcom appoints Google executive Rick Osterloh to board - Investing.com
Dexcom Appoints Rick Osterloh to Board of Directors - The Joplin Globe
DexCom, Inc. Appoints Rick Osterloh to Board of Directors, Effective February 26, 2026 - marketscreener.com
Westfield Capital Management Co. LP Trims Stake in DexCom, Inc. $DXCM - MarketBeat
Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership - Insider Monkey
Fox Run Management L.L.C. Purchases Shares of 18,368 DexCom, Inc. $DXCM - MarketBeat
HighTower Advisors LLC Lowers Stake in DexCom, Inc. $DXCM - MarketBeat
DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals - Yahoo Finance
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Morningstar
Assessing DexCom (DXCM) Valuation After Short Term Gains And A 14.5% Undervaluation Narrative - simplywall.st
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars - The Globe and Mail
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars - The Motley Fool
Dexcom announces upcoming conference presentation - marketscreener.com
Dexcom Announces Upcoming Conference Presentation - The Joplin Globe
Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat - Finviz
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
I Tried Dexcom’s Stelo, a Glucose Biosensor, for 30 Days. Here’s What I Learned - Athletech News
I Tried Dexcom’s Stelo Glucose Biosensor for 30 Days. Here’s What I Learned - Athletech News
DexCom: How Product Innovation and Feature Adoption Are Expanding Its Diabetes Opportunity! - Smartkarma
Dexcom’s CEO to Chair AdvaMed’s Diabetes Sector - Medical Product Outsourcing
DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership - Insider Monkey
DexCom, Inc. (DXCM): Investor Outlook Highlights 16.94% Upside Potential and Strong Buy Ratings - DirectorsTalk Interviews
Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story? - Yahoo Finance
Public Sector Pension Investment Board Decreases Holdings in DexCom, Inc. $DXCM - MarketBeat
Is DexCom Inc. a strong growth stockJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - mfd.ru
DexCom, Inc. $DXCM Shares Bought by Premier Fund Managers Ltd - MarketBeat
Jupiter Asset Management Ltd. Takes Position in DexCom, Inc. $DXCM - MarketBeat
Aurora Investment Counsel Makes New $2.29 Million Investment in DexCom, Inc. $DXCM - MarketBeat
DexCom G7 Rollout And Expansion Shape Growth And Competitive Outlook - Sahm
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term - Yahoo Finance
King Luther Capital Management Corp Reduces Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
SENS Eversense 365 Integrated With twiist Gains Full Availability - TradingView
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 25,094 Shares of DexCom, Inc. $DXCM - MarketBeat
The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call - The Globe and Mail
The Strong Earnings Posted By DexCom (NASDAQ:DXCM) Are A Good Indication Of The Strength Of The Business - simplywall.st
The 5 Most Interesting Analyst Questions From DexCom's Q4 Earnings Call - Finviz
Vanguard Group Inc. Purchases 1,133,638 Shares of DexCom, Inc. $DXCM - MarketBeat
P/E Ratio Insights for DexCom - Benzinga
NEOS Investment Management LLC Boosts Position in DexCom, Inc. $DXCM - Defense World
DexCom, Inc. $DXCM Shares Sold by Shell Asset Management Co. - MarketBeat
What Wall Street predicts for DexCom Inc. stock pricePortfolio Gains Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Dexcom G6 Glucose Monitor Lawsuit Claims Manufacturer’s Device Modifications Resulted in Teen’s Death - AboutLawsuits.com
Dexcom Stock After Volatility: Is This High-Growth Medtech Now Mispriced? - AD HOC NEWS
Aberdeen Group plc Increases Position in DexCom, Inc. $DXCM - MarketBeat
What DexCom (DXCM)'s Margin Beat And Reaffirmed 2026 Outlook Means For Shareholders - simplywall.st
The DexCom, Inc. (NASDAQ:DXCM) Yearly Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook - Bitget
10 Best Medical Technology Stocks to Invest In - Insider Monkey
DexCom Earnings Call Highlights Margin Rebound, Growth - The Globe and Mail
Is DexCom Inc. in a consolidation phaseJuly 2025 Final Week & Weekly Breakout Watchlists - mfd.ru
DexCom (DXCM) Margin Expansion To 17.9% Reinforces Bullish Earnings Narratives - Sahm
DexCom’s AI Stelo Upgrade Faces Valuation Questions After Share Declines - Sahm
DexCom Expands G7 And Stelo To Deepen CGM Ecosystem Engagement - Yahoo Finance
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - sharewise.com
DexCom (DXCM) Maintains Buy Rating Despite Lowered Price Target - GuruFocus
Key facts: DexCom reports $2.8B profit; Wells Fargo cuts price target - TradingView
Why Is DexCom (DXCM) Stock Rocketing Higher Today - Finviz
0.25%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):